Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Onconic Therapeutics Inc banner
O

Onconic Therapeutics Inc
KOSDAQ:476060

Watchlist Manager
Onconic Therapeutics Inc
KOSDAQ:476060
Watchlist
Price: 14 730 KRW 5.21%
Market Cap: ₩668.9B
Write Note Create Alert Ask AI

Wall St Price Targets

Price Targets Summary
Onconic Therapeutics Inc

Wall Street analysts forecast Onconic Therapeutics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Onconic Therapeutics Inc is 21 420 KRW with a low forecast of 21 210 KRW and a high forecast of 22 050 KRW.

Lowest Forecast
Wall Street Target
₩21 210
44% Upside
Average Forecast
Wall Street Target
₩21 420
45% Upside
Highest Forecast
Wall Street Target
₩22 050
50% Upside
Lowest Forecast
Price Target
21 210 KRW
44% Upside
Average Forecast
Price Target
21 420 KRW
45% Upside
Highest Forecast
Price Target
22 050 KRW
50% Upside
Onconic Therapeutics Inc Competitors:
Price Targets
ARDX
Ardelyx Inc
323% Upside
SSRM
SSR Mining Inc
16% Upside
ARDX
Ardelyx Inc
323% Upside
SSRM
SSR Mining Inc
16% Upside

Revenue
Forecast

59% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
59% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for Onconic Therapeutics Inc

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Onconic Therapeutics Inc

Operating Income
Forecast

138% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
138% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for Onconic Therapeutics Inc

Pre-Tax Income
Forecast

355% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
355% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Onconic Therapeutics Inc

Net Income
Forecast

206% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
206% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for Onconic Therapeutics Inc

Continue Research

Summary
intrinsic value, competitors valuation, and company profile.
DCF Valuation
stock valuation using Discount Cash Flow valuation method.
Relative Valuation
stock valuation using valuation multiples.
Wall St Estimates
price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Onconic Therapeutics Inc's stock price target?
Price Target
21 420 KRW

According to Wall Street analysts, the average 1-year price target for Onconic Therapeutics Inc is 21 420 KRW with a low forecast of 21 210 KRW and a high forecast of 22 050 KRW.

Back to Top
ALPHA SPREAD
Follow us
Join 353,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett